Synthes, Inc. Chairman Emeritus Hansjörg Wyss Joins Osiris Therapeutics, Inc. As A Strategic Advisor

Osiris Therapeutics, Inc. (NASDAQ: OSIR), the leading stem cell company focused on developing and marketing products in wound care, orthopedic and sports medicine markets, announced today that Hansjörg Wyss will serve as a strategic advisor to the company. Mr. Wyss was the founder and a major shareholder of Synthes and served as its Chairman until the company was sold to Johnson & Johnson in 2012 for $19.7 billion.

Help employers find you! Check out all the jobs and post your resume.